NCT03436238

Brief Summary

The purpose of this multicentre, prospective, observational study is to identify robust biochemical markers that predict adverse cardiovascular outcomes and mortality in patients undergoing major abdominal surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,269

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
May 2017Dec 2026

Study Start

First participant enrolled

May 15, 2017

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
6.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

2.9 years

First QC Date

February 10, 2018

Last Update Submit

March 15, 2026

Conditions

Keywords

PerioperativeBiomarkersTroponinProdrenomedullinEndothelinPerioperative ComplicationsMyocardial injuryMajor adverse cardiovascular events

Outcome Measures

Primary Outcomes (2)

  • 30-day mortality

    All-cause mortality at 30 days post-surgery.

    30 days post surgery

  • 30-day MACCE

    Major adverse cardio- cerebrovascular events (MACCE) at 30 days post-surgery.

    30 days post surgery

Secondary Outcomes (2)

  • 12-month mortality

    12 months post surgery

  • 12-month MACCE

    12 months post surgery

Other Outcomes (2)

  • Net reclassification index (NRI)

    30 days post surgery

  • Long term mortality

    3 years and 5 years

Study Arms (1)

MINSS cohort

Adult patients \>= 50 years old undergoing elective, major, abdominal surgery requiring at least one overnight stay in hospital. Major abdominal surgery is defined as those classified as major OR major/complex by the Surgical Outcome Risk Tool (SORT) (www.sortsurgery.com).

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective, major abdominal surgery at participating centres, requiring general anaesthesia, and requiring at least one overnight stay.

You may qualify if:

  • Adult patients undergoing elective, major abdominal surgery\*.
  • (\*Major abdominal surgery requiring general anaesthesia, and requiring at least one overnight stay. Major abdominal surgery is defined as those classified as major OR major/complex by the Surgical Outcome Risk Tool (SORT) (www.sortsurgery.com).
  • In essence major surgery is one that penetrates and exposes a body cavity or produces a substantial impairment of physical or physiologic function or involves extensive dissection or transection. Examples of a major abdominal surgery include, but are not limited to, any procedure involving a laparotomy or laparoscopic procedures of the stomach, duodenum, small and large intestine and rectum. It also includes but is not limited to procedures on the reproductive system (total abdominal hysterectomy, salpingo-oophorectomy) and genitourinary system (nephrectomy, cystectomy).)

You may not qualify if:

  • Patients undergoing the following surgical procedures will NOT be eligible:
  • transplantation
  • trauma
  • endocrine
  • vascular
  • endovascular
  • ACS at presentation (clinical assessment or documentation)
  • New or decompensated congestive heart failure at presentation (clinical assessment or documentation)
  • Documented severe aortic stenosis (valve area \< 1cm2)
  • Reduced LVEF (\<40%); if no LVEF is available, it will be assumed to be \>40%
  • Inability to follow the procedures of the study, e.g. due to language problems, dementia, etc. of the participant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Kristianstad KRYH Hospital

Kristianstad, Skåne County, Sweden

Location

Eskilstuna Hospital

Eskilstuna, Sweden

Location

Ryhov County Hospital

Jönköping, Sweden

Location

Skane University Hospital Lund

Lund, Sweden

Location

Skane University Hospital Malmö

Malmo, Sweden

Location

Vrinnevi Hospital

Norrköping, Sweden

Location

Department of Anaesthesia and Intensive Care, Linkoeping University Hospital, Region Östergötland

Linköping, Östergötland County, 50185, Sweden

Location

Related Publications (2)

  • Falt M, Ahman R, Hammarskjold F, Lyckner S, Jawad M, Andersson U, Fredrikson M, Sperber J, Elander L, De Geer L, Didriksson H, Jonsson C, Andersson H, Chew MS. Long-term outcomes of time-dependent phenotypes of perioperative myocardial injury☆. BJA Open. 2025 Jun 4;14:100422. doi: 10.1016/j.bjao.2025.100422. eCollection 2025 Jun.

  • Chew MS, Puelacher C, Patel A, Hammarskjold F, Lyckner S, Kollind M, Jawad M, Andersson U, Fredrikson M, Sperber J, Johnsson P, Elander L, Zeuchner J, Linhardt M, De Geer L, Rolander WG, Gagno G, Didriksson H, Pearse R, Mueller C, Andersson H. Identification of myocardial injury using perioperative troponin surveillance in major noncardiac surgery and net benefit over the Revised Cardiac Risk Index. Br J Anaesth. 2022 Jan;128(1):26-36. doi: 10.1016/j.bja.2021.10.006. Epub 2021 Nov 29.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michelle S Chew, MBBS, PhD

    Linkoeping University and Region Östergötland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Senior Consultant

Study Record Dates

First Submitted

February 10, 2018

First Posted

February 19, 2018

Study Start

May 15, 2017

Primary Completion

March 31, 2020

Study Completion (Estimated)

December 31, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations